JYNT - Joint Corp-The Stock Price, Fair Value and News

12.28USD-0.31 (-2.46%)Market Closed

Market Summary

USD12.28-0.31

Market Closed

-2.46%

JYNT Stock Price

View Fullscreen

JYNT RSI Chart

JYNT Valuation

Market Cap

181.5M

Price/Earnings (Trailing)

-18.61

Price/Sales (Trailing)

1.54

EV/EBITDA

15.71

Price/Free Cashflow

18.75

JYNT Price/Sales (Trailing)

JYNT Profitability

Operating Margin

91.04%

EBT Margin

1.39%

Return on Equity

-39.41%

Return on Assets

-11.19%

Free Cashflow Yield

5.33%

JYNT Fundamentals

JYNT Revenue

Revenue (TTM)

117.7M

JYNT Earnings

Earnings (TTM)

-9.8M

Earnings Growth (Yr)

-1.5K%

Earnings Growth (Qtr)

-1.4K%

Breaking Down JYNT Revenue

Last 7 days

2.2%

Last 30 days

-3.5%

Last 90 days

30.8%

Trailing 12 Months

-18.9%

How does JYNT drawdown profile look like?

JYNT Financial Health

Current Ratio

1.32

JYNT Investor Care

Shares Dilution (1Y)

1.41%

Diluted EPS (TTM)

-0.65

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	107.5M	0	0	117.7M
2022	84.9M	89.8M	95.5M	101.3M
2021	62.4M	69.8M	75.2M	80.0M
2020	51.4M	52.8M	55.5M	58.7M
2019	38.7M	41.1M	44.5M	48.5M
2018	28.0M	30.8M	33.5M	36.7M
2017	21.9M	23.0M	24.0M	25.0M
2016	15.6M	17.1M	18.5M	20.5M
2015	8.1M	9.8M	12.1M	13.8M
2014	6.2M	6.5M	6.8M	7.1M
2013	0	0	0	6.0M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Joint Corp-The

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Sep 21, 2023	bandera partners llc	bought	2,092,100	9.59233	218,101	-
Sep 20, 2023	bandera partners llc	bought	215,165	9.49284	22,666	-
Sep 19, 2023	bandera partners llc	bought	893	9.4	95.00	-
Sep 18, 2023	bandera partners llc	bought	225,954	9.43006	23,961	-
Sep 15, 2023	bandera partners llc	bought	69,859	9.4686	7,378	-
Sep 14, 2023	bandera partners llc	bought	420,801	9.1286	46,097	-
Sep 13, 2023	bandera partners llc	bought	240,102	9.28219	25,867	-
Sep 12, 2023	bandera partners llc	bought	123,570	9.49591	13,013	-
Sep 11, 2023	bandera partners llc	bought	78,007	9.4257	8,276	-
Sep 07, 2023	bandera partners llc	bought	194,120	9.1106	21,307	-

Which funds bought or sold JYNT recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	FIFTH THIRD BANCORP	unchanged	-	34,500	130,600	-%
Apr 23, 2024	AMALGAMATED BANK	reduced	-76.34	-13,000	6,000	-%
Apr 22, 2024	MetLife Investment Management, LLC	unchanged	-	4,985	77,274	-%
Apr 12, 2024	Bridge City Capital, LLC	added	75.2	167,515	288,822	0.10%
Apr 12, 2024	AdvisorNet Financial, Inc	unchanged	-	556	2,103	-%
Apr 02, 2024	Avondale Wealth Management	added	192	185,675	248,140	0.17%
Mar 22, 2024	PNC Financial Services Group, Inc.	sold off	-100	-216	-	-%
Mar 11, 2024	VANGUARD GROUP INC	reduced	-1.56	491,942	9,908,560	-%
Mar 05, 2024	GREENWOOD CAPITAL ASSOCIATES LLC	added	95.69	386,436	740,354	0.05%
Mar 01, 2024	GOLDMAN SACHS GROUP INC	added	100	3,721,010	6,978,970	-%

Are Funds Buying or Selling JYNT?

Are funds buying JYNT calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own JYNT

No. of Funds

Unveiling Joint Corp-The's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	6.99%	1,031,068	SC 13G/A
Jan 26, 2024	blackrock inc.	6.8%	1,004,619	SC 13G/A
Jan 12, 2024	millennium management llc	0.5%	68,815	SC 13G/A
Nov 08, 2023	bandera partners llc	26.7%	3,937,296	SC 13D/A
Sep 25, 2023	bandera partners llc	26.7%	3,937,296	SC 13D/A
Sep 15, 2023	bandera partners llc	24.9%	3,672,473	SC 13D/A
Aug 11, 2023	bandera partners llc	23.6%	3,466,560	SC 13D
Mar 08, 2023	blackrock inc.	6.8%	992,289	SC 13G/A
Feb 13, 2023	bandera partners llc	17.4%	2,529,748	SC 13G/A
Feb 09, 2023	blackrock inc.	6.5%	941,786	SC 13G/A

Recent SEC filings of Joint Corp-The

View All Filings

Date Filed	Form Type	Document
Apr 19, 2024	DEF 14A	DEF 14A
Mar 08, 2024	10-K	Annual Report
Mar 07, 2024	8-K	Current Report
Feb 13, 2024	SC 13G/A	Major Ownership Report
Jan 26, 2024	SC 13G/A	Major Ownership Report

Peers (Alternatives to Joint Corp-The)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	449.3B	371.6B	0.31%	-0.92%	20.08	1.21	14.64%	11.24%
CI	103.0B	195.3B	-0.92%	38.85%	19.17	0.53	8.17%	-20.79%
CVS	85.3B	357.8B	-14.21%	-7.01%	10.21	0.24	10.95%	93.52%
HCA	84.4B	65.0B	-2.46%	13.22%	16.11	1.3	7.86%	-7.11%
CNC	40.8B	154.0B	-1.12%	9.99%	15.09	0.26	6.54%	124.79%
DVA	11.6B	12.1B	-1.51%	52.05%	16.83	0.96	4.57%	23.40%
UHS	11.5B	14.3B	-6.67%	17.96%	16.03	0.81	6.59%	6.24%
MID-CAP
CHE	9.3B	2.3B	-4.23%	9.23%	34.26	4.12	6.06%	9.17%
ACHC	6.6B	2.9B	-6.62%	-3.50%	-303.27	2.24	12.20%	-107.93%
AMN	2.2B	3.8B	-8.18%	-34.26%	10.28	0.57	-27.73%	-52.50%
AMEH	2.1B	1.4B	-5.68%	1.59%	33.83	1.48	21.19%	34.42%
SMALL-CAP
ADUS	1.5B	1.1B	-7.02%	-15.70%	24.79	1.46	11.31%	35.83%
BKD	1.3B	3.0B	4.49%	59.95%	-6.76	0.42	6.74%	20.73%
BEAT	54.0M	-	-6.82%	-	-3.69	-	-	-12.94%
AMS	18.7M	21.3M	14.29%	7.64%	35.15	0.88	8.00%	-62.25%

Joint Corp-The News

Latest updates

Joint Corp-The Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3	2018Q2
Revenue	-100.0%	-	28,450	27,678	26,450	24,887	22,237	21,895	20,782	20,004	17,330	17,038	15,411	12,590	13,644	13,875	12,726	11,170	10,679	9,968	9,242	8,805
Cost Of Revenue	16.1%	2,872	2,475	2,466	2,337	2,257	2,111	2,203	2,090	1,824	1,547	1,941	1,712	1,368	1,486	1,634	1,427	1,299	1,206	1,202	1,085	1,052
S&GA Expenses	-0.2%	26,372	26,414	23,697	23,116	23,872	20,158	19,143	16,825	15,659	14,568	12,320	11,993	11,018	11,404	10,901	10,629	9,401	8,425	8,229	8,061	7,566
EBITDA Margin	-17.1%	0.09*	0.11*	0.07*	0.06*	0.07*	0.11*	0.12*	0.15*	0.16*	0.14*	-	-	-	-	-	-	-	-	-	-	-
Interest Expenses	-	-	-	-	-	-	-	-	-	-	36.00	-	-	-	-	-	-	-	-	-	-	-
Income Taxes	1194.4%	10,898	842	629	-24.01	-477	-59.08	27.00	-389	-535	-610	-7,882	76.00	118	-65.93	32.00	7.00	10.00	1.00	70.00	-50.17	6.00
Earnings Before Taxes	-104.5%	-143	3,168	1,393	707	-1,349	-54.86	523	1,854	2,550	1,129	2,751	1,680	233	749	1,325	624	472	951	507	-257	-44.89
EBT Margin	-61.8%	0.01*	0.04*	0.01*	0.00*	0.01*	0.06*	0.08*	0.11*	0.12*	0.09*	-	-	-	-	-	-	-	-	-	-	-
Net Income	-574.7%	-11,041	2,326	763	731	-871	4.00	497	2,244	3,085	1,739	10,633	1,604	116	815	1,292	617	462	953	437	-207	-50.84
Net Income Margin	-402.0%	-0.08*	0.03*	0.01*	0.00*	0.02*	0.07*	0.09*	0.24*	0.24*	0.23*	-	-	-	-	-	-	-	-	-	-	-
Free Cashflow	-54.0%	2,217	4,824	3,601	3,060	-3,257	-1,092	1,175	1,293	4,456	-68.89	-	-	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	-11.6%	87.00	99.00	99.00	100	93.00	89.00	87.00	87.00	87.00	82.00	78.00	67.00	66.00	52.00	50.00	46.00	44.00	42.00	36.00	34.00	23.00
Current Assets	56.0%	44.00	28.00	23.00	24.00	18.00	19.00	18.00	26.00	27.00	25.00	24.00	23.00	25.00	22.00	19.00	15.00	13.00	11.00	12.00	11.00	11.00
Cash Equivalents	13.1%	18.00	16.00	14.00	15.00	10.00	10.00	9.00	18.00	20.00	20.00	19.00	18.00	21.00	18.00	15.00	11.00	9.00	8.00	9.00	8.00	9.00
Net PPE	-	-	-	-	-	-	-	-	-	-	-	-	-	9.00	8.00	8.00	8.00	7.00	6.00	5.00	4.00	4.00
Goodwill	-13.0%	7.00	8.00	8.00	8.00	8.00	8.00	8.00	5.00	5.00	5.00	5.00	0.00	5.00	4.00	4.00	4.00	4.00	4.00	3.00	3.00	3.00
Liabilities	-1.4%	62.00	63.00	64.00	64.00	61.00	58.00	57.00	56.00	57.00	52.00	52.00	44.00	45.00	43.00	42.00	39.00	38.00	38.00	34.00	32.00	23.00
Current Liabilities	21.3%	34.00	28.00	25.00	25.00	23.00	22.00	20.00	21.00	21.00	21.00	22.00	17.00	18.00	16.00	15.00	13.00	14.00	13.00	12.00	11.00	10.00
Shareholder's Equity	-29.8%	25.00	35.00	35.00	35.00	33.00	31.00	30.00	31.00	30.00	30.00	27.00	23.00	21.00	9.00	7.00	7.00	6.00	4.00	3.00	2.00	1.00
Retained Earnings	-101.6%	-21.91	-10.86	-10.15	-9.83	-12.15	-12.92	-13.65	-12.78	-12.78	-13.30	-15.52	-18.61	-20.09	-31.10	-32.71	-32.82	-33.64	-35.35	-35.97	-36.43	-37.38
Additional Paid-In Capital	1.1%	47.00	47.00	46.00	46.00	46.00	45.00	45.00	44.00	44.00	44.00	43.00	42.00	41.00	41.00	40.00	40.00	39.00	39.00	39.00	39.00	38.00
Shares Outstanding	0.0%	15.00	15.00	15.00	15.00	15.00	15.00	14.00	14.00	14.00	14.00	14.00	14.00	-	-	-	-	-	-	-	-	-
Minority Interest	0%	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	100*	100*	100*	100*	100*	100*	100*	100*	100*	-100*	100*
Float	-	-	-	124	-	-	-	137	-	-	-	880	-	-	-	206	-	-	-	236	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	-11.0%	3,383	3,802	1,469	6,025	5,177	4,217	-1,382	198	2,781	3,437	6,743	883	4,276	3,871	1,565	1,472	2,817	1,868	2,377	460	3,564
Share Based Compensation	-6.7%	491	526	417	266	330	306	340	324	229	297	284	246	207	212	216	250	184	186	179	172	159
Cashflow From Investing	-18.3%	-1,304	-1,103	-2,579	-1,200	-5,611	-3,523	-7,475	-1,289	-2,878	-2,386	-6,537	-951	-2,375	-320	-684	-1,221	-1,182	-3,749	-1,004	-1,201	-544
Cashflow From Financing	15.4%	-6.21	-7.33	58.00	130	16.00	239	47.00	26.00	18.00	108	621	-2,743	473	87.00	2,959	2,077	-988	262	44.00	85.00	40.00
Buy Backs	-99.9%	1*	1.00	-	3.00	-	3.00	-	3.00	-1*	90.00	-	618	28.00	488*	-	4.00	1*	20.00	-	-	-

JYNT Income Statement

2023-12-31

Consolidated Income Statements - USD ($)	12 Months Ended
Consolidated Income Statements - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Revenues:
Total revenues	$ 117,696,356	$ 101,252,310
Cost of revenues:
Total cost of revenues	10,546,558	9,171,063
Selling and marketing expenses	16,541,990	13,962,709
Depreciation and amortization	8,582,203	6,646,622
General and administrative expenses	81,466,088	70,233,447
Total selling, general and administrative expenses	106,590,281	90,842,778
Net loss on disposition or impairment	2,632,604	410,215
(Loss) income from operations	(2,073,087)	828,254
Other income (expense), net	3,711,843	(133,101)
Income before income tax expense	1,638,756	695,153
Income tax expense	11,390,953	68,448
Net (loss) income	$ (9,752,197)	$ 626,705
(Loss) earnings per share:
Basic (loss) earnings per share (in dollars per share)	$ (0.66)	$ 0.04
Diluted (loss) earnings per share (in dollars per share)	$ (0.65)	$ 0.04
Basic weighted average shares (in shares)	14,688,115	14,488,314
Diluted weighted average shares (in shares)	14,935,217	14,868,093
Revenues from company-owned or managed clinics
Revenues:
Total revenues	$ 70,718,880	$ 59,422,294
Royalty fees
Revenues:
Total revenues	29,160,831	26,190,531
Franchise fees
Revenues:
Total revenues	2,882,895	2,441,325
Cost of revenues:
Cost of revenues	9,063,375	7,803,404
Advertising fund revenue
Revenues:
Total revenues	8,321,043	7,456,696
Software fees
Revenues:
Total revenues	5,086,562	4,290,739
Cost of revenues:
Cost of revenues	1,483,183	1,367,659
Other revenues
Revenues:
Total revenues	$ 1,526,145	$ 1,450,725

JYNT Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 18,153,609	$ 9,745,066
Restricted cash	1,060,683	805,351
Accounts receivable	3,718,924	3,911,272
Deferred franchise and regional development costs, current portion	1,047,430	1,054,060
Prepaid expenses and other current assets	2,439,837	2,098,359
Assets held for sale	17,915,055	0
Total current assets	44,335,538	17,614,108
Property and equipment, net	11,044,317	17,475,152
Operating lease right-of-use asset	12,413,221	20,587,199
Deferred franchise and regional development costs, net of current portion	5,203,936	5,707,678
Intangible assets, net	5,020,926	10,928,295
Goodwill	7,352,879	8,493,407
Deferred tax assets ($1.1 million and $1.0 million attributable to VIEs as of December 31, 2023 and 2022)	1,031,648	11,928,152
Deposits and other assets	748,394	756,386
Total assets	87,150,859	93,490,377
Current liabilities:
Accounts payable	1,625,088	2,966,589
Accrued expenses	1,963,009	1,069,610
Co-op funds liability	1,060,683	805,351
Payroll liabilities ($0.7 million and $0.6 million attributable to VIEs as of December 31, 2023 and 2022)	3,485,744	2,030,510
Operating lease liability, current portion	3,756,328	5,295,830
Finance lease liability, current portion	25,491	24,433
Deferred franchise fee revenue, current portion	2,516,554	2,468,601
Deferred revenue from company clinics ($1.6 million and $4.7 million attributable to VIEs as of December 31, 2023 and 2022)	4,463,747	7,471,549
Upfront regional developer fees, current portion	362,326	487,250
Other current liabilities	483,249	597,294
Liabilities to be disposed of ($3.6 million attributable to VIEs as of December 31, 2023)	13,831,863	0
Total current liabilities	33,574,082	23,217,017
Operating lease liability, net of current portion	10,914,997	18,672,719
Finance lease liability, net of current portion	38,016	63,507
Debt under the Credit Agreement	2,000,000	2,000,000
Deferred franchise fee revenue, net of current portion	13,597,325	14,161,134
Upfront regional developer fees, net of current portion	1,019,316	1,500,278
Other liabilities	1,235,241	1,287,879
Total liabilities	62,378,977	60,902,534
Commitments and contingencies (note 10)
Stockholders' equity:
Series A preferred stock, $0.001 par value; 50,000 shares authorized, 0 issued and outstanding, as of December 31, 2023 and 2022	0	0
Common stock, $0.001 par value; 20,000,000 shares authorized, 14,783,757 shares issued and 14,751,633 shares outstanding as of December 31, 2023 and 14,560,353 shares issued and 14,528,487 outstanding as of December 31, 2022	14,783	14,560
Additional paid-in capital	47,498,151	45,558,305
Treasury stock 32,124 shares as of December 31, 2023 and 31,866 shares as of December 31, 2022, at cost	(860,475)	(856,642)
Accumulated deficit	(21,905,577)	(12,153,380)
Total The Joint Corp. stockholders' equity	24,746,882	32,562,843
Non-controlling Interest	25,000	25,000
Total equity	24,771,882	32,587,843
Total liabilities and stockholders' equity	$ 87,150,859	$ 93,490,377

About Joint Corp-The

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

CEO	Mr. Peter D. Holt
WEBSITE	thejoint.com
INDUSTRY	Healthcare Plans
EMPLOYEES	359

Joint Corp-The Frequently Asked Questions

What is the ticker symbol for Joint Corp-The? What does JYNT stand for in stocks?

JYNT is the stock ticker symbol of Joint Corp-The. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Joint Corp-The (JYNT)?

As of Wed Apr 24 2024, market cap of Joint Corp-The is 181.45 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of JYNT stock?

You can check JYNT's fair value in chart for subscribers.

What is the fair value of JYNT stock?

You can check JYNT's fair value in chart for subscribers. The fair value of Joint Corp-The is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Joint Corp-The is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for JYNT so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Joint Corp-The a good stock to buy?

The fair value guage provides a quick view whether JYNT is over valued or under valued. Whether Joint Corp-The is cheap or expensive depends on the assumptions which impact Joint Corp-The's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for JYNT.

What is Joint Corp-The's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Apr 24 2024, JYNT's PE ratio (Price to Earnings) is -18.61 and Price to Sales (PS) ratio is 1.54. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. JYNT PE ratio will change depending on the future growth rate expectations of investors.